RX TO OTC Switches
Susan B. Levy Consulting, LLC works with clients on Rx to OTC switch projects to provide complete lifecycle management from assessing opportunities to developing and implementing successful commercial and regulatory strategies.
We drive short-term and long-term success and have led numerous first-in-class switches.
Rx to OTC Switch Experience
Since 2011, the team at Susan B. Levy Consulting, LLC has:
- Led the strategy, planning and program implementation of multiple first-in-class Rx to OTC switch candidates
- Assessed Rx to OTC switch potential for multiple Rx products
- Contributed to long-term life cycle management strategy for NCE’s
- Assisted Rx companies with Rx to OTC switch outlicensing strategies
- Supported top ten consumer healthcare company’s efforts to evaluate and secure in-licensing candidates in various therapeutic categories
- Accelerated timelines for existing Rx to OTC switch programs
- Contributed to the Rx to OTC switch evaluation process for an OTC company
- Attended Rx to OTC switch advisory committee meetings
- Analyzed factors most likely to determine marketplace success for Rx to OTC switches
- Develop best practices and benchmarks for Rx to OTC switch partnerships
Rx to OTC Switch Thought Leadership and Education
Susan B. Levy Consulting, LLC has:
- Led Rx to OTC switch workshops for several pharmaceutical and consumer healthcare companies
- Presented and led workshops at numerous Rx to OTC switch conferences internationally and for the Consumer Healthcare Products Association
- Wrote articles on Rx to OTC switches
